Martin Vollmer, biopharma program manager at Agilent Technologies, spoke to LCGC International about the evolving importance of glucagon-like peptide-1 (GLP-1) therapeutics and the challenges they ...

Physicists Prof. Dr. Ingo Rehberg from the University of Bayreuth and Dr. Peter Blümler from Johannes Gutenberg University ...

As the number of particles in a physical system increases, its properties can change and different phase transitions (i.e., ...

There are no global process profiles. Each process profile includes a "compatible_printers" field with an array of compatible printer variant names. You can validate your profiles using both the ...